- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Adrianne Appel2023-11-13T20:15:00
New guidance from the Department of Health and Human Services (HHS) provides descriptions of major health regulations, including the False Claims Act, and how to avoid getting ensnared by them.
The General Compliance Program Guidance (GCPG), released Nov. 6, is the first in a series of updated, voluntary, nonbinding guidance documents issued by the HHS’s Office of Inspector General (OIG), the body that enforces health regulations.
The GCPG is designed to apply generally to the healthcare industry, from doctors to pharmaceutical manufacturers, and help all such entities self-monitor their compliance and prevent waste, fraud, and abuse, the OIG said. The HHS last updated its guidance in 2008.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Indiana-based Community Health Network agreed to pay $345 million as part of a settlement with the Department of Justice resolving allegations it overcompensated physicians it employed at a rate that violated the Stark Law.
Saint Joseph’s Medical Center agreed to pay $80,000 as part of a settlement with the Department of Health and Human Services’ Office for Civil Rights for potential violations of the Health Insurance Portability and Accountability Act.
Cardiac Imaging and its chief executive agreed to pay a total of more than $85 million to settle charges levied by the Department of Justice addressing alleged violations of the False Claims Act regarding unlawful kickbacks.
Any product that uses AI needs to be safety assessed for its entire lifespan under new rules that went into effect recently across the EU. Experts warned companies using AI to tailor products could be classed as “manufacturers” and face the same duty of care as developed.
When lawmakers slam the U.K.’s chief financial regulator as “incompetent,” it not only opens the doors for others to pile criticism on it, but it sparks a debate about how the organization can be improved–or removed.
The U.K. Financial Conduct Authority apologized to investors in peer-to-peer investment firm Collateral for not acting swiftly enough to prevent Collateral from defrauding its customers.
